Form 8-K · Current report

Kimberly-Clark 8-K, filed Nov 5, 2026

Filed
CIK
0000055785
Accession no.
0001628280-26-070514
AI-generated summary

Summary

Kimberly-Clark reported third-quarter 2026 net sales of $4.1 billion, down 0.4 percent with organic sales down 1.3 percent, and reaffirmed its 2026 standalone outlook. The quarter followed the completion of its Kenvue transaction earlier in the week and the July 1 completion of the International Family Care and Professional business divestiture; Chairman and CEO Mike Hsu said underlying business momentum remains strong and cited industry-leading productivity gains.

Key points

  • Third-quarter net sales were $4.1 billion, roughly flat year over year, as organic sales declined 1.3 percent on a roughly 270 basis point headwind from a China social media disruption and North American retailer inventory movements.
  • Adjusted operating profit was $677 million, down 0.9 percent, and adjusted gross margin was 35.5 percent, down 130 basis points.
  • Adjusted EPS from continuing operations were $1.70, up 17.2 percent, while diluted EPS attributable to Kimberly-Clark were $5.37, including a $1.4 billion pre-tax gain on the completed IFP transaction.
  • Quarterly results included $106 million of charges tied to the Kenvue acquisition and $55 million tied to the 2024 Transformation Initiative.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 2.02Results of Operations and Financial Condition
  • 9.01Financial Statements and Exhibits

From the filing

Item 2.02 Results of Operations and Financial Condition. Attached and incorporated herein by reference as Exhibit 99.1 is a copy of the press release of Kimberly-Clark Corporation (the "Corporation"), dated November 5, 2026 reporting the Corporation’s results of operations for the quarter ended September 30, 2026. The information, including exhibits attached hereto, in Item 2.02 of this Current Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Kimberly-Clark in Readster

Add Kimberly-Clark to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.